Skip to main content

Peer Review reports

From: High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer

Original Submission
1 Dec 2020 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
7 Feb 2021 Reviewed Reviewer Report
8 Feb 2021 Reviewed Reviewer Report
24 Feb 2021 Author responded Author comments - Yasuhiro Matsumura
Resubmission - Version 4
24 Feb 2021 Submitted Manuscript version 4
25 Feb 2021 Author responded Author comments - Yasuhiro Matsumura
Resubmission - Version 5
25 Feb 2021 Submitted Manuscript version 5
2 Mar 2021 Reviewed Reviewer Report
8 Mar 2021 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
15 Mar 2021 Editorially accepted
23 Mar 2021 Article published 10.1186/s12885-021-08046-6

You can find further information about peer review here.

Back to article page